SLAMF1 Antikörper (AA 34-213)
Kurzübersicht für SLAMF1 Antikörper (AA 34-213) (ABIN7874063)
Target
Alle SLAMF1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 34-213
-
Verwendungszweck
- SLAMF1 Antibody / SMAM / CD150
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Recombinant human protein (amino acids K34-N213) was used as the immunogen for the SLAMF1 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the SLAMF1 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the SLAMF1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- SLAMF1 (Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1))
-
Andere Bezeichnung
- SLAMF1
-
Hintergrund
- Signaling lymphocytic activation molecule 1 is a protein that in humans is encoded by the SLAMF1 gene. SLAMF1 Antibody: The signaling lymphocyte-activation molecule family member 1 (SLAMF1) is a novel receptor on T cells that potentiates T cell expansion in a CD28-independent manner. SLAMF1 is predominantly expressed by hematopoietic tissues. Reports suggest that the extracellular domain of SLAMF1 is the receptor for the measles virus and acts as a co-activator on both T and B cells. It is thought to interact with SH2D1A and with PTPN11 via its cytoplasmic domain. Mutations of the SLAM associated gene may be associated with X-linked lympho-proliferative disease (XLP).
-
UniProt
- Q13291
Target
-